NYSE · Medical - Instruments & Supplies

ATR (ATR) Stock

$136.77 +2.10% NYSE: ATR Healthcare

Valuation

MetricValue
Price$136.77
Market Cap$8.73B
P/E Ratio19.32
P/B Ratio2.72
P/S Ratio1.87
EPS (TTM)$5.88
52-Week High$164.28
52-Week Low$103.23
Dividend Yield1.66%

Financials & Margins

MetricValue
ROE14.73%
ROA7.48%
ROCE18.87%
Gross Margin13.56%
Operating Margin13.56%
Net Margin9.98%
Debt/Equity0.54
Current Ratio1.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.2B$3.3B$3.5B$3.6B$3.8B
Operating Profit$347.0M$379.0M$404.0M$496.0M$512.0M
Net Profit$244.0M$239.0M$284.0M$375.0M$393.0M
EPS$3.60$3.59$4.25$5.53$5.88
Op Margin10.8%11.4%11.6%13.9%13.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$4.1B$4.2B$4.5B$4.4B$5.3B
Total Liabilities$2.2B$2.1B$2.1B$1.9B$2.5B
Cash$123.0M$142.0M$224.0M$224.0M$402.0M
Borrowings$1.2B$1.2B$1.2B$1.1B$1.5B

Latest News

ATR: Raising target price to $135.00 Argus Research · Jul 15, 2026 Packaging, Forest Products Face Lackluster Demand, Weak Volumes, BofA Says MT Newswires · Jul 14, 2026 BofA Upgrades AptarGroup to Buy From Neutral, Price Target is $173 MT Newswires · Jul 14, 2026 Aptar Named Among Top 100 of America’s Best Companies by TIME Business Wire · Jul 13, 2026 Aptar Releases 2025 Corporate Sustainability Report Business Wire · Jun 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$363.0M$479.0M$575.0M$643.0M$570.0M
Investing Cash Flow$-765.0M$-611.0M$-643.0M$-691.0M$-601.0M
Financing Cash Flow$-20.0M$-68.0M$-16.0M$-14.0M$-365.0M
Net Cash Flow$-182.0M$20.0M$81.0M$0$178.0M
Free Cash Flow$56.0M$163.0M$257.0M$349.0M$300.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA10.49
FCF Yield4.49%
Quick Ratio1.14
Interest Coverage9.66
Return 1Y-15.88%
Return 3Y11.82%
Return 5Y2.17%

Ownership

Insiders Held0.88%
Institutions Held97.12%
Institutions Float Held97.98%
Institutional HolderSharesReport Date
Blackrock Inc.6,083,5182026-03-31
State Farm Mutual Automobile Insurance Co4,744,5642026-03-31
Vanguard Portfolio Management LLC3,767,7722026-03-31
Morgan Stanley3,375,7962026-03-31
Vanguard Capital Management LLC2,885,2972026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVTR $13.36 -2.34% -9.79 $9.04B 0.00%
GMED $80.19 +2.48% 20.18 $10.81B 0.00%
GRFSGrifols, S.A. $7.27 -0.27% 14.60 $6.15B 1.24%
HALO $81.48 -0.55% 23.58 $9.66B 0.00%
HSIC $86.51 +0.89% 22.31 $9.85B 0.00%

About ATR

ATR is led by CEO Stephan Tanda, employs 14,000 people, headquartered in Crystal Lake, US, publicly traded since 1993.

ATR stock trades at $136.77 with a market capitalization of $8.73B. The stock is valued at a price-to-earnings (P/E) ratio of 19.32, price-to-book of 2.72, price-to-sales of 1.87. Over the past 52 weeks the stock has ranged between $103.23 and $164.28, and currently trades 16.7% below its 52-week high. It pays a dividend yielding 1.66%.

On profitability, ATR generates a return on equity (ROE) of 14.73%, above the typical market average, return on capital employed of 18.87%, an operating margin of 13.56%, a net profit margin of 9.98%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides